Of note, the fact that our intracardiac shMTA1 xenografts exhibited reduced formation of bone metastasis suggests that it is possible to prevent homing of primary prostate tumor cells to the bone microenvironment by targeting MTA1. This evidence concerns the gene MTA1 and prostate neoplasm.